PAM
AMAG

Paradigm Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Paradigm Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,800
Closed -$132K – 674
2016
Q4 		$132K Sell
3,800
-100
-3% -$2.99K 0.03% 343
2016
Q3 		$95.6K Buy
+3,900
New +$97.5K 0.02% 436
2015
Q4 		– Sell
-900
Closed -$35.8K – 875
2015
Q3 		$35.8K Buy
+900
New +$55.9K ﹤0.01% 706

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paradigm Asset Management's AMAG Position: Q1 2017 in Review

Paradigm Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 3,800 shares — an estimated $132K sold.

Paradigm Asset Management first reported a position in AMAG in Q3 2015 and held it in 3 quarters. The position peaked at $132K in Q4 2016. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Paradigm Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 3,800 AMAG Pharmaceuticals shares in Q1 2017, an estimated $132K.
  • Paradigm Asset Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Paradigm Asset Management's AMAG Pharmaceuticals position peaked at $132K in Q4 2016.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Paradigm Asset Management's 13F filing for Q1 2017, filed 12 May 2017.